Sclerotherapy with 3% polidocanol foam for the treatment of mucocutaneous bridges and/or residual piles after open excisional hemorrhoidectomy
Updates in Surgery · 2024
DOI: 10.1007/s13304-024-01798-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Updates in Surgery, 2024. Verfasst von Gaetano Gallo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Sapienza University of Rome, Rome, Italy. ga.gallo@uniroma1.it. Hauptthemen laut MEDLINE: Polidocanol, Sclerotherapy, Hemorrhoids, Hemorrhoidectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Injection sclerotherapy is an effective and safe treatment in selected cases. It might be used as the first treatment for I-III degree hemorrhoidal disease (HD), but also as a bridge therapy for more severe cases not amenable to invasive treatments. However, concerning the long-term recurrence rate, open excisional hemorrhoidectomy remains the gold standard in cases of III- and IV-degree HD. In this context, it is recommended to perform the excision of no more than three piles and to preserve the muco-cutaneous bridges to avoid post-operative anal stenosis. The aim of this study is to evaluate surgical outcomes and efficacy of the combined treatment of open excisional hemorrhoidectomy and the use of ST on the remnant muco-cutaneous bridges/residual piles. This was a single-center retrospective study and a total of 18 patients with IV-degree HD, aged between 18 and 75 years with symptomatic HD according to the Goligher classification, were enrolled between January 2023 and June 2023 and their follow-up continued until October 2023 after reaching 3 months of follow-up. The Hemorrhoidal Disease Symptom Score (HDSS), the Short Health Scale for HD (SHS-HD) score and the Vaizey Incontinence Score were used to assess symptoms and their impact on quality of life and continence. A total of 77.8% (14/18) of the patients were symptom-free (hemorrhoidal disease symptom score (HDSS) score = 0) after 3 months. Moreover, a statistically significant decrease in the median HDSS and short health scale for HD (SHS-HD) score was registered from 16 preoperatively (T0) to 2 at 3-month follow-up (T3). Neither post-operative bleeding nor any type of complications occurred. The use of sclerotherapy in combination with the traditional open excisional hemorrhoidectomy has shown promising results. Further structured studies are needed and greater dissemination and education of the general surgeon on the subject is necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Sapienza University of Rome, Rome, Italy. ga.gallo@uniroma1.it.
- Department of Surgery, Department of Medicine of Precision and Regenerative and Jonic Area (DiMePRe-J,), University Hospital of Bari, Bari, Italy.
- Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Gallo, G., Laforgia, R., Goglia, M., & Lobascio, P. (2024). Sclerotherapy with 3% polidocanol foam for the treatment of mucocutaneous bridges and/or residual piles after open excisional hemorrhoidectomy. Updates in Surgery. https://doi.org/10.1007/s13304-024-01798-3
Vancouver
Gallo G, Laforgia R, Goglia M, Lobascio P. Sclerotherapy with 3% polidocanol foam for the treatment of mucocutaneous bridges and/or residual piles after open excisional hemorrhoidectomy. Updates in Surgery. 2024. doi:10.1007/s13304-024-01798-3
BibTeX
@article{Gallo2024,
author = {Gallo, Gaetano and Laforgia, Rita and Goglia, Marta and Lobascio, Pierluigi},
title = {Sclerotherapy with 3% polidocanol foam for the treatment of mucocutaneous bridges and/or residual piles after open excisional hemorrhoidectomy},
journal = {Updates in Surgery},
year = {2024},
doi = {10.1007/s13304-024-01798-3}
}
EUVIMED